VERANDERTE PHOSPHODIESTERASE-AKTIVITAT DER LEUKOZYTEN BEI ATOPISCHEM EKZEM

Translated title of the contribution: Abnormal leukocyte phosphodiesterase activity in atopic dermatitis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Leukocytes of patients with atopic eczema exhibit a variety of biochemical abnormalities, particularly an alteration in cyclic nucleotide metabolism. The basic defect is an elevation of phosphodiesterase activity in these cells, which leads to a diminished modulation of cellular immune function by cAMP. This, in turn, leads to an elevation of IgE synthesis and enhanced release of inflammatory mediators from mast cells and basophils. The phosphodiesterase defect offers new approaches to the treatment of atopic eczema.

Original languageGerman
Pages (from-to)258-261
Number of pages4
JournalHautarzt
Volume38
Issue number5
StatePublished - 1987

Fingerprint

Phosphoric Diester Hydrolases
Atopic Dermatitis
Leukocytes
Basophils
Cyclic Nucleotides
Mast Cells
Immunoglobulin E
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

VERANDERTE PHOSPHODIESTERASE-AKTIVITAT DER LEUKOZYTEN BEI ATOPISCHEM EKZEM. / Hanifin, Jon.

In: Hautarzt, Vol. 38, No. 5, 1987, p. 258-261.

Research output: Contribution to journalArticle

@article{26cd23bee59b4cf7803fda75cb53ccb1,
title = "VERANDERTE PHOSPHODIESTERASE-AKTIVITAT DER LEUKOZYTEN BEI ATOPISCHEM EKZEM",
abstract = "Leukocytes of patients with atopic eczema exhibit a variety of biochemical abnormalities, particularly an alteration in cyclic nucleotide metabolism. The basic defect is an elevation of phosphodiesterase activity in these cells, which leads to a diminished modulation of cellular immune function by cAMP. This, in turn, leads to an elevation of IgE synthesis and enhanced release of inflammatory mediators from mast cells and basophils. The phosphodiesterase defect offers new approaches to the treatment of atopic eczema.",
author = "Jon Hanifin",
year = "1987",
language = "German",
volume = "38",
pages = "258--261",
journal = "Der Hautarzt",
issn = "0017-8470",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - VERANDERTE PHOSPHODIESTERASE-AKTIVITAT DER LEUKOZYTEN BEI ATOPISCHEM EKZEM

AU - Hanifin, Jon

PY - 1987

Y1 - 1987

N2 - Leukocytes of patients with atopic eczema exhibit a variety of biochemical abnormalities, particularly an alteration in cyclic nucleotide metabolism. The basic defect is an elevation of phosphodiesterase activity in these cells, which leads to a diminished modulation of cellular immune function by cAMP. This, in turn, leads to an elevation of IgE synthesis and enhanced release of inflammatory mediators from mast cells and basophils. The phosphodiesterase defect offers new approaches to the treatment of atopic eczema.

AB - Leukocytes of patients with atopic eczema exhibit a variety of biochemical abnormalities, particularly an alteration in cyclic nucleotide metabolism. The basic defect is an elevation of phosphodiesterase activity in these cells, which leads to a diminished modulation of cellular immune function by cAMP. This, in turn, leads to an elevation of IgE synthesis and enhanced release of inflammatory mediators from mast cells and basophils. The phosphodiesterase defect offers new approaches to the treatment of atopic eczema.

UR - http://www.scopus.com/inward/record.url?scp=0023194006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023194006&partnerID=8YFLogxK

M3 - Article

C2 - 3038785

AN - SCOPUS:0023194006

VL - 38

SP - 258

EP - 261

JO - Der Hautarzt

JF - Der Hautarzt

SN - 0017-8470

IS - 5

ER -